London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
30/06/2021 · Additionally, a patent application describing a number of crystalline forms of a TYK2 inhibitor for medicinal applications, filed by Sareum in April 2020, was published on 14 October 2021. This type of patent is standard pharmaceutical industry practice and an important step to fully protect the intellectual property surrounding the Company’s research programmes and to extend the life span .
Good evening labman. from July RNS as follows:-
US Patent Notice of Allowance for Sareum's SDC-1802
Cambridge, UK, 30 July 2021 - Sareum Holdings plc (AIM: SAR), the specialist drug development company delivering targeted small molecule therapeutics to improve the treatment of cancer and autoimmune diseases, announces that the United States Patent and Trademark Office has issued a Notice of Allowance for a patent in respect of an invention associated with Sareum's proprietary SDC-1802 TYK2/JAK1 Kinase Inhibitor Programme (the "SDC-1802 Programme").
The patent (US Patent Application no. 16/343,639) will protect the SDC-1802 molecule and pharmaceutical preparations thereof as a therapeutic to treat cancer selected from pancreatic, colorectal and kidney cancers, melanoma, and B-cell lymphoma by inhibiting TYK2 kinase. This programme is in preclinical development.
The Company expects that the patent will be granted within three months, subject to certain formalities being completed.
This was ongoing as far as I know of the 'crystallisation of a compound ' that was originally applied for in April 2020.
I will look through old history and dig out for you.
Regards
SOG, forgive my ignorance here but has there been any concrete evidence from SAR regarding the secret patent.
Was the US patent information discovered discovered by one of of our posters on advn anything to do with it and if so how do we know?.
Many thanks again Sad, Look forward to more info as and when you have time, really getting interesting now. I must have missed the the RNS on the secret patent, don't recall seeing one
Crogy34. You are welcome. my feelings of the secret patent is that the patent is for the 'crystallisation of a compound' using this method it enables the molecules to be arranged precisely.
if there were another compound invented we would have heard many moons ago. New or modified compound with intended target and hence received RNS notification.
i will post more on this later for you. But I will stress here the importance of molecular structure and formation into compounds to control cell signalling cannot be over emphasised.
Regards
Many thanks Sad, I understand that we probably did not get an RNS re the US patent being granted as we had one to say it would do on the 26th. However I thought we would get one when the secret patent surfaced, but so far nothing. As you believe news re licensing/ partnership is close maybe that's the reason. Always appreciate yours and all the other LTH's valuable opinions and knowledge
Crogy. With these protective patents in place, my belief is that news with regards to on licensing/partnership will now be imminent. Significant value added to Sareum.
Regards
It is the fact that 1 buy is more than the sells on its own Silver. Seems wrong to me
On LSE since 10 AM 56 buys and 6 sells but price down until a few minutes ago .. bazaar!!
The patent/ patents are big news.
Effectively by using the crystallisation of a compound to ensure maximum purity they now cover compounds ie 1801 and 1802 for a period of 17 years from the 26th of October 2021.
it may well prove extremely likely that should sareum use this method of manufacture for FLT+3 then this will also benefit from 17 years of patent protection. Although original patents worldwide for FLT+3 were granted around 2013 ( from memory) it effectively increase patent protection on FLT+3 alone from 2033 to 2038.
Patent protection on all of wholly owned Sareum compounds increased by the patented protection of its manufacturing process. Ie no other bugger can formulate our compounds to the exact standards required.
So yes very much underestimated.
Longer term protection of our compounds
100% potential purity obtainable by using this manufacturing process.
GAME ON!
Regards
Agreed Alan. The pressure mounts!!
The science will tell.
How this isn't blue is beyond me.
All those buys and some of them big compared to a couple of sells with one reasonable one.
Are they keeping this down so someone can get in on the cheap?
It seems very strange that with our US patent getting granted and our secret patent surfacing it has all gone quiet on that front. To me both issues seemed big news, but for some reason they seem to have gotten lost. Is it that there could be sensitive negotiations going on behind the scenes that we are not party too?